AtriCure (ATRC) Tops Q2 EPS by 4c

Go back to AtriCure (ATRC) Tops Q2 EPS by 4c

BTIG Trims PT on AtriCure (ATRC) to $19; Management 'Disconnect' Causes Concern

August 8, 2016 11:17 AM EDT

BTIG cut its price target on Buy-rated AtriCure (NASDAQ: ATRC) from $34 down to $19 after the company reported Q2 results late last week.

Analyst Sean Lavin commented, ATRC reported a relatively in-line but messy quarter with the core business coming in soft while increased focus on nContact... More

Needham & Company Cuts Price Target on AtriCure (ATRC) to $20; Reiterates Buy

August 5, 2016 8:34 AM EDT

Needham & Company maintained a Buy rating on AtriCure Inc. (NASDAQ: ATRC), and cut the price target to $20.00 (from $23.00), following the company's 2Q earnings report. Revenue was reported at $39.7M, a slight beat to the consensus estimate of $39.8M. EPS was ($0.26), ahead of consensus of ($0.30). ATRC lowered its... More

AtriCure (ATRC) Guidance Reset Should Be Positive Clearing Event - Piper Jaffray

August 5, 2016 8:27 AM EDT

Piper Jaffray analyst Brooks West cut his price target on AtriCure Inc. (NASDAQ: ATRC) to $17.00 (from $22.00) following Q2 results, but maintained an Overweight rating saying guidance reset could be a positive clearing event.

West commented, "AtriCure reported 2Q16 revenues of $39.7M (+21.5% cc) vs. consensus of... More